Benzimidazole derivatives useful in treatment of vallinoid recep tor TRPV1 related disorders

Details for Australian Patent Application No. 2007282186 (hide)

Owner AstraZeneca AB

Inventors Labrecque, Denis; Brown, William; Johnstone, Shawn

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007282186

PCT Pub. Number WO2008/018827

Priority 60/837,249 11.08.06 US

Filing date 10 August 2007

Wipo publication date 14 February 2008

Acceptance publication date 7 July 2011

International Classifications

C07D 235/06 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/4184 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2008/018827 Priority application(s): WO2008/018827

7 July 2011 Application Accepted

  Published as AU-B-2007282186

3 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007282204-Apparatus for manufacturing molten irons and method for manufacturing molten irons using the same

2007282182-A process for the preparation of optically active cyclopropylamines